Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew revision entry v3.3.2 was added and v3.2.0 was removed from the page history. This does not modify any study data or displayed content.SummaryDifference0.1%

- Check28 days agoChange DetectedThe top-of-page government funding/status notice was removed. It previously warned that data may not be up to date and inquiries may be delayed.SummaryDifference0.5%

- Check49 days agoChange DetectedA new version entry (Version 26, submitted 2025-08-12) appears in the history, reflecting updated study status and recruitment details for NCT05516498.SummaryDifference0.1%

- Check70 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference11%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

- Check92 days agoChange DetectedPatch update: the page revision moves from v3.0.1 to v3.0.2. The 'Back to Top' element has been removed, with no substantive changes to core content, pricing, stock, or time slot information.SummaryDifference0.7%

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.